Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Healthc Q ; 23(3): 12-14, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-33243360

RESUMEN

The rise in harms associated with misuse of substances such as cannabis, alcohol and opioids is a public health issue gaining increasing importance in Canada. Taking a closer look at who is being hospitalized, and for which substances, helps inform efforts to improve access to services for youth. Between 2017 and 2018, hospitalizations for harm caused by substance use accounted for about one in 20 of all hospital stays among youths aged 10-24 years in Canada. Cannabis use was documented in nearly 40% of these hospitalizations, while alcohol was associated with 26%. Approximately one in every six youths (17%), who were hospitalized for harm caused by substance use, was hospitalized more than once for substance use within the same year.


Asunto(s)
Hospitalización/estadística & datos numéricos , Trastornos Relacionados con Sustancias/epidemiología , Adolescente , Consumo de Bebidas Alcohólicas , Canadá/epidemiología , Cannabis , Niño , Femenino , Humanos , Masculino , Trastornos Mentales/epidemiología , Adulto Joven
3.
Environ Mol Mutagen ; 45(1): 44-55, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15605355

RESUMEN

An interlaboratory study was performed to validate an anti-CD71/flow cytometry-based technique for enumerating micronucleated reticulocytes (MN-RETs) in mouse peripheral blood. These experiments were designed to address International Workshop on Genotoxicity Test Procedures validation criteria by evaluating the degree of correspondence between MN-RET measurements generated by flow cytometry (FCM) with those obtained using traditional microscopy-based methods. In addition to these cross-methods data, flow cytometric MN-RET measurements for each blood sample were performed at two separate sites in order to evaluate the reproducibility of data between laboratories. In these studies, groups of male CD-1 mice were treated with vehicle (saline or vegetable oil), a negative control (saline or vegetable oil), or four dose levels of five known genotoxicants (clastogens: cyclophosphamide, benzo[a]pyrene, 5-fluorouracil, methotrexate; aneugen: vincristine sulfate). Exposure occurred on 3 consecutive days via intraperitoneal injection, and blood samples were obtained approximately 24 hr after the final treatment. MN-RET frequencies were determined for each sample based on the analysis of 2,000 (microscopy) and 20,000 (FCM) reticulocytes. Regardless of the method utilized, each genotoxic agent was observed to cause statistically significant increases in the frequency of MN-RETs, and each response occurred in a dose-dependent manner. Spearman's correlation coefficient (rs) for FCM versus microscopy-based MN-RET measurements (nine experiments, 252 paired measurements) was 0.740, indicating a high degree of correspondence between methods. The rs value for all flow cytometric MN-RET measurements performed at the two independent sites was 0.857 (n = 248), suggesting that the automated method is highly transferable between laboratories. Additionally, the flow cytometric system offered advantages relative to microscopy-based scoring, including a greater number of cells analyzed, much faster analysis times, and a greater degree of objectivity. Collectively, data presented in this report suggest that the overall performance of mouse peripheral blood micronucleus tests is enhanced by the use of the flow cytometric scoring procedure.


Asunto(s)
Citometría de Flujo/métodos , Pruebas de Micronúcleos/métodos , Reticulocitos , Animales , Antígenos CD , Antígenos de Diferenciación de Linfocitos B , Benzo(a)pireno/toxicidad , Ciclofosfamida/toxicidad , Relación Dosis-Respuesta a Droga , Masculino , Metotrexato/toxicidad , Ratones , Mutágenos/toxicidad , Receptores de Transferrina , Vincristina/toxicidad
4.
J Lipid Res ; 44(5): 893-901, 2003 May.
Artículo en Inglés | MEDLINE | ID: mdl-12562868

RESUMEN

To investigate whether dietary fatty acid (FA) composition and energy restriction (ER) interactively influence obese (ob) gene expression, rats consumed diets containing beef tallow, safflower, or fish oil ad libitum (AL) or at 60% AL intake. Circulating leptin concentrations were higher (P < 0.0001) after AL feeding, but were not influenced by dietary fat. ER decreased (P < 0.0001) weight gain and visceral adipose weight, which were positively correlated (r = 0.40 P < 0.001, r = 0.58 P < 0.0001) with circulating leptin levels. Visceral adipose ob mRNA levels were greater in animals fed unsaturated fats, particularly safflower oil, which had the highest ob mRNA levels. Circulating leptin levels did not parallel ob mRNA levels, except for the greater abundance detected in AL adipose in comparison to ER animals. In addition, visceral FA profiles reflected dietary fat source and were influenced by an interaction of dietary fat and energy. These data demonstrate that dietary fat, particularly from a plant or marine source, and ER interactively influence ob mRNA levels; however, alterations in ob mRNA do not confer changes in circulating leptin, with the exception of ER, which is a key determinant. Thus, dietary intake is an important regulator of leptin production; however, the significance of these modest changes in diet-induced obese animals requires further study.


Asunto(s)
Tejido Adiposo/química , Grasas de la Dieta/administración & dosificación , Ingestión de Energía , Ácidos Grasos/análisis , Leptina/biosíntesis , Tejido Adiposo/efectos de los fármacos , Tejido Adiposo/metabolismo , Animales , Grasas/administración & dosificación , Aceites de Pescado/administración & dosificación , Regulación de la Expresión Génica/efectos de los fármacos , Insulina/análisis , Insulina/sangre , Leptina/análisis , Leptina/genética , Masculino , ARN Mensajero/efectos de los fármacos , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Aceite de Cártamo/administración & dosificación , Aumento de Peso/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...